James W. Vardiman

Overview

Best Publications

• The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

  Daniel A. Arber;Attilio Orazi;Robert Hasserjian;Jürgen Thiele

  9969
  Citations

• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

  James W. Vardiman;Jüergen Thiele;Daniel A. Arber;Richard D. Brunning

  6008
  Citations

• World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

  Nancy Lee Harris;Elaine S. Jaffe;Jacques Diebold;Georges Flandrin

  5442
  Citations

• The World Health Organization (WHO) classification of the myeloid neoplasms.

  James W. Vardiman;Nancy Lee Harris;Richard D. Brunning

  3139
  Citations

• Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms.

  A Tefferi;J W Vardiman

  1398
  Citations

• Diagnostic criteria and classification of mastocytosis: a consensus proposal

  Peter Valent;Hans P. Horny;Luis Escribano;B. Jack Longley

  1338
  Citations

• The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997

  N. L. Harris;E. S. Jaffe;J. Diebold;G. Flandrin

  1170
  Citations

• Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

  M M Le Beau;K S Albain;R A Larson;J W Vardiman

  977
  Citations

• Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

  Ayalew Tefferi;Juergen Thiele;Attilio Orazi;Hans Michael Kvasnicka

  907
  Citations

• Absence of the Wild-Type Allele Predicts Poor Prognosis in Adult de Novo Acute Myeloid Leukemia with Normal Cytogenetics and the Internal Tandem Duplication of FLT3 A Cancer and Leukemia Group B Study

  Susan P. Whitman;Kellie J. Archer;Lan Feng;Claudia Baldus

  905
  Citations

• Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

  Peter Paschka;Guido Marcucci;Amy S. Ruppert;Krzysztof Mrózek

  837
  Citations

• Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712).

  John C. Byrd;Bercedis L. Peterson;Vicki A. Morrison;Kathleen Park

  836
  Citations

• Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

  Sonali M. Smith;Michelle M. Le Beau;Dezheng Huo;Theodore Karrison

  776
  Citations

• Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association

  M M Le Beau;R A Larson;M A Bitter;J W Vardiman

  696
  Citations

• What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.

  Wendy Stock;Mei La;Ben Sanford;Clara D. Bloomfield

  687
  Citations

• Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease

  Janet D. Rowley;Harvey M. Golomb;James W. Vardiman

  654
  Citations

• Evidence for a 15; 17 translocation in every patient with acute promyelocytic leukemia

  Richard A Larson;Koji Kondo;James W Vardiman;Ann E Butler

  596
  Citations

• The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

  N L Harris;E S Jaffe;J Diebold;G Flandrin

  575
  Citations

• The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

  N L Harris;E S Jaffe;J Diebold;G Flandrin

  544
  Citations

• The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.

  N L Harris;E S Jaffe;J Diebold;G Flandrin

  465
  Citations